MichaelLloydWallaceMD

Pathology • Pittsburgh, PA

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Wallace is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wallace's full profile

Already have an account?

Office
522 Alpha Dr
Pittsburgh, PA 15238
Phone+1 412-968-9266

Fax+1 412-968-5673

Education & Training

Duke University HospitalFellowship, Dermatopathology, 1996 - 1997
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1993 - 1996
George Washington UniversityResidency, Surgery, 1992 - 1993
Johns Hopkins University School of MedicineInternship, Transitional Year, 1991 - 1992
George Washington University School of Medicine and Health SciencesClass of 1991

Certifications & Licensure

NY State Medical License 2017 - 2026
CT State Medical License 2022 - 2025
MD State Medical License 2001 - 2025
OH State Medical License 2019 - 2025
WV State Medical License 2001 - 2025
CA State Medical License 1993 - 2024
NC State Medical License 2005 - 2024
PA State Medical License 2001 - 2024
VA State Medical License 1997 - 2024
FL State Medical License 2002 - 2020
IL State Medical License 2001 - 2014
TX State Medical License 2007 - 2014
American Board of Pathology Anatomic Pathology
American Board of Pathology Dermatopathology
Join now to see all

Publications & Presentations

PubMed

15 citations
Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE).
Christopher T. Leffler, Vikram S Brar, Michael L. Wallace
American Journal of Ophthalmology. 2017-07-01
31 citations
Widespread metastatic eccrine porocarcinoma.
Rajat Goel, Melissa J. Contos, Michael L. Wallace
Journal of the American Academy of Dermatology. 2003-11-01
56 citations
Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Michael L. Wallace, Teri A. Longacre, Bruce R. Smoller
Modern Pathology. 1995-12-01

Press Mentions

Editor’s Choice: The Emerging Role of Histologic Disease Activity Assessment in Ulcerative ColitisDecember 16th, 2018